Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Sher

Showing results (41-50 of 159) with videos related to

Pageof 16
Sort By:
International Journal of Radiation Oncology, Biology, Physics|July 7, 2018
Cost-Effectiveness Analysis of Intensity Modulated Radiation Therapy Versus Proton Therapy for Oropharyngeal Squamous Cell CarcinomaDavid J Sher, Roy B Tishler, Nhat-Long Pham, et al.
Oral Oncology|November 3, 2020
Comparative cost analysis between definitive radiotherapy and transoral surgery for oropharyngeal squamous cell carcinoma: A SEER-Medicare analysisDavid J Sher, Jingsheng Yan, Andrew T Day, et al.
JAMA Otolaryngology-- Head & Neck Surgery|October 17, 2018
Commercial Claims-Based Comparison of Survival and Toxic Effects of Definitive Radiotherapy vs Primary Surgery in Patients With Oropharyngeal Squamous Cell CarcinomaDavid J Sher, Abiy Agiro, Siting Zhou, et al.
American Journal of Clinical Oncology|January 1, 2013
Cost-effectiveness analysis of SBRT versus IMRT for low-risk prostate cancerDavid J Sher, Ravi B Parikh, Shawnda Mays-Jackson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2011
Survival outcomes after radiation therapy for stage III non-small-cell lung cancer after adoption of computed tomography-based simulationAileen B Chen, Bridget A Neville, David J Sher, et al.
Cancer|February 13, 2013
Death from high-risk prostate cancer versus cardiovascular mortality with hormonal therapy: a decision analysisNataniel H Lester-Coll, Samuel Z Goldhaber, David J Sher, et al.
International Journal of Radiation Oncology, Biology, Physics|October 31, 2008
Partial-breast irradiation versus whole-breast irradiation for early-stage breast cancer: a cost-effectiveness analysisDavid J Sher, Eve Wittenberg, W Warren Suh, et al.
Journal of the National Cancer Institute|October 2, 2015
Prevalence and Predictors of Inappropriate Delivery of Palliative Thoracic Radiotherapy for Metastatic Lung CancerMatthew Koshy, Renuka Malik, Usama Mahmood, et al.
Journal of the National Cancer Institute|January 9, 2016
ResponseMatthew Koshy, Renuka Malik, Usama Mahmood, et al.
International Journal of Radiation Oncology, Biology, Physics|February 13, 2016
Cost-Effectiveness Analysis of Chemoradiation Therapy Versus Transoral Robotic Surgery for Human Papillomavirus-Associated, Clinical N2 Oropharyngeal CancerDavid J Sher, Mary Jo Fidler, Roy B Tishler, et al.
Pageof 16

Showing results (41-50 of 159) with videos related to

Sort By:
Pageof 16
International Journal of Radiation Oncology, Biology, Physics|July 7, 2018
Cost-Effectiveness Analysis of Intensity Modulated Radiation Therapy Versus Proton Therapy for Oropharyngeal Squamous Cell CarcinomaDavid J Sher, Roy B Tishler, Nhat-Long Pham, et al.
Oral Oncology|November 3, 2020
Comparative cost analysis between definitive radiotherapy and transoral surgery for oropharyngeal squamous cell carcinoma: A SEER-Medicare analysisDavid J Sher, Jingsheng Yan, Andrew T Day, et al.
JAMA Otolaryngology-- Head & Neck Surgery|October 17, 2018
Commercial Claims-Based Comparison of Survival and Toxic Effects of Definitive Radiotherapy vs Primary Surgery in Patients With Oropharyngeal Squamous Cell CarcinomaDavid J Sher, Abiy Agiro, Siting Zhou, et al.
American Journal of Clinical Oncology|January 1, 2013
Cost-effectiveness analysis of SBRT versus IMRT for low-risk prostate cancerDavid J Sher, Ravi B Parikh, Shawnda Mays-Jackson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2011
Survival outcomes after radiation therapy for stage III non-small-cell lung cancer after adoption of computed tomography-based simulationAileen B Chen, Bridget A Neville, David J Sher, et al.
Cancer|February 13, 2013
Death from high-risk prostate cancer versus cardiovascular mortality with hormonal therapy: a decision analysisNataniel H Lester-Coll, Samuel Z Goldhaber, David J Sher, et al.
International Journal of Radiation Oncology, Biology, Physics|October 31, 2008
Partial-breast irradiation versus whole-breast irradiation for early-stage breast cancer: a cost-effectiveness analysisDavid J Sher, Eve Wittenberg, W Warren Suh, et al.
Journal of the National Cancer Institute|October 2, 2015
Prevalence and Predictors of Inappropriate Delivery of Palliative Thoracic Radiotherapy for Metastatic Lung CancerMatthew Koshy, Renuka Malik, Usama Mahmood, et al.
Journal of the National Cancer Institute|January 9, 2016
ResponseMatthew Koshy, Renuka Malik, Usama Mahmood, et al.
International Journal of Radiation Oncology, Biology, Physics|February 13, 2016
Cost-Effectiveness Analysis of Chemoradiation Therapy Versus Transoral Robotic Surgery for Human Papillomavirus-Associated, Clinical N2 Oropharyngeal CancerDavid J Sher, Mary Jo Fidler, Roy B Tishler, et al.
Pageof 16